Yuan Zhi
Stock Analyst at B. Riley Securities
(2.02)
# 3,047
Out of 5,118 analysts
32
Total ratings
41.94%
Success rate
-3.68%
Average return
Main Sectors:
Stocks Rated by Yuan Zhi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RADX Radiopharm Theranostics | Reiterates: Buy | $13 → $16 | $5.37 | +197.95% | 3 | Dec 16, 2025 | |
| RDNT RadNet | Maintains: Buy | $71 → $87 | $72.81 | +19.49% | 2 | Dec 1, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $8 → $14 | $8.75 | +60.00% | 3 | Nov 18, 2025 | |
| CATX Perspective Therapeutics | Maintains: Buy | $12 → $11 | $2.73 | +302.93% | 4 | Nov 18, 2025 | |
| MIR Mirion Technologies | Reiterates: Buy | $17 → $22 | $23.77 | -7.45% | 3 | Jul 23, 2025 | |
| TOI The Oncology Institute | Initiates: Buy | $6 | $3.65 | +64.38% | 1 | Jul 16, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.2 → $1 | $0.97 | +3.01% | 2 | May 15, 2025 | |
| AGEN Agenus | Maintains: Buy | $42 → $18 | $3.19 | +464.26% | 2 | Aug 14, 2024 | |
| CYRX Cryoport | Upgrades: Buy | $19 → $15 | $9.55 | +57.07% | 4 | Jul 31, 2024 | |
| CTSO Cytosorbents | Reiterates: Buy | $3 | $0.66 | +354.48% | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $79 | $34.68 | +127.80% | 3 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $16 | $1.42 | +1,026.76% | 4 | Dec 11, 2023 |
Radiopharm Theranostics
Dec 16, 2025
Reiterates: Buy
Price Target: $13 → $16
Current: $5.37
Upside: +197.95%
RadNet
Dec 1, 2025
Maintains: Buy
Price Target: $71 → $87
Current: $72.81
Upside: +19.49%
Tango Therapeutics
Nov 18, 2025
Maintains: Buy
Price Target: $8 → $14
Current: $8.75
Upside: +60.00%
Perspective Therapeutics
Nov 18, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $2.73
Upside: +302.93%
Mirion Technologies
Jul 23, 2025
Reiterates: Buy
Price Target: $17 → $22
Current: $23.77
Upside: -7.45%
The Oncology Institute
Jul 16, 2025
Initiates: Buy
Price Target: $6
Current: $3.65
Upside: +64.38%
Hyperfine
May 15, 2025
Maintains: Buy
Price Target: $1.2 → $1
Current: $0.97
Upside: +3.01%
Agenus
Aug 14, 2024
Maintains: Buy
Price Target: $42 → $18
Current: $3.19
Upside: +464.26%
Cryoport
Jul 31, 2024
Upgrades: Buy
Price Target: $19 → $15
Current: $9.55
Upside: +57.07%
Cytosorbents
May 15, 2024
Reiterates: Buy
Price Target: $3
Current: $0.66
Upside: +354.48%
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $34.68
Upside: +127.80%
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $1.42
Upside: +1,026.76%